A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries

Journal Title: International Journal of Drug Regulatory Affairs - Year 2019, Vol 7, Issue 1

Abstract

To ensure quality, efficacy, and safety of drugs is the prime objective of any country and respective drug regulatory authority. Countries have their own regulatory setup to ensure the proper execution of drug regulatory guidelines in their country. There are several regional organization in world, ASEAN is one of them. It is Association of Southeast nations. ASEAN is very well representing its countries on global platform. The step of harmonization of drug regulatory guidelines by ASEAN is seen as major step taken by an Asian regional organization. ASEAN is an emerging market and every country has its own needs. As research and development sector is only developed in Singapore in ASEAN region so, generics emerge as a tool for other countries to fulfill UHC goals and Vision 2020 ASEAN. Every country has the different procedure for generic drug registration application approval. To clearly understand the procedure of generic drug registration application approval process we have gone through various guidelines and literature. There are 10 members in ASEAN i.e. Singapore, Malaysia, Thailand, Indonesia, Philippines, Brunei Darussalam, Laos PDR, Myanmar, Vietnam, and Cambodia. Each one’s generic drug approval process, requirements and effects on pharmaceutical trade after implementation of ACTD is explained in this research work. This research work also includes the statistical analysis and suggestions on how other countries and regional organization follow the model of ASEAN for drug regulatory harmonization procedure.

Authors and Affiliations

Jyoti Ghangas, Neha Jain, Anshuman Sinha

Keywords

Related Articles

ORAL FAST DISSOLVING DRUG DELIVERY SYSTEM: A MODERN APPROACH FOR PATIENT COMPLIANCE

This review represents importance of mouth dissolving films as compared to other oral dosage forms. Fast dissolving oral drug delivery system are solid dosage form which disintegrate or dissolve within seconds when place...

STEVIA AN UNTOUCHED NATURE’S GIFT CAN BE A BOON TO DIABETIC

Plants and fungi are a vital part of healthcare. Over 80% of the global population rely on traditional medicine, much of which is based on plant remedies. Traditional Chinese medicine alone uses over 5,000 plant species....

DRUG PRODUCT REGISTRATION IN SEMI-REGULATED MARKET

There found a diversity of regulatory requirement in Semi regulated market. This region consists of mainly the countries from Asia pacific, Latin America, Eastern Europe, Africa and Gulf countries. Countries from Asia pa...

Requirements for introducing Medical devices in India and US market - A comparative study of regulations

Medical devices are widely used in the healthcare sector and are manufactured by the pharmaceutical industry. The Government of India has periodically come out with certain guidelines, to be followed by the companies tha...

CURRENT REGULATION OF MEDICAL GASES IN INDIA AND FUTURE ASPECTS

Generally medical gases are administered or supplied directly to the patients. They should be manufactured and transferred with the highest quality possible as per standards and limits decided by the different regulatory...

Download PDF file
  • EP ID EP495697
  • DOI 10.22270/ijdra.v7i1.297
  • Views 158
  • Downloads 0

How To Cite

Jyoti Ghangas, Neha Jain, Anshuman Sinha (2019). A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries. International Journal of Drug Regulatory Affairs, 7(1), 13-24. https://europub.co.uk./articles/-A-495697